ERBB2 and breast neoplasm: In spontaneous primary tumors of the breast in the MMTV-Her2/neu model, genetic analyses indicated that loss of Id1 and/or Id3 was insufficient to inhibit tumor growth and needed to be combined with suboptimal doses of chemotherapy to cause regression59.